Skip to main content
. 2017 May 26;6(7):1500–1511. doi: 10.1002/cam4.1063

Figure 4.

Figure 4

Incidence of NEC in the subgroups of patients according to the schedules of cytarabine included in the induction protocols for hematological remission. The numbers of patients affected and not affected are inside the columns.